The language of sleepiness in obstructive sleep apnea beyond the Epworth.

PURPOSE: Obstructive sleep apnea (OSA) is underdiagnosed, partially from variable clinical presentations. Emphasis is often placed on Epworth Sleepiness Scale (ESS), a subjective measure of sleepiness, but variable in OSA. We hypothesized that daytime complaints measured with Language of Sleepiness Questionnaire (LOS) in OSA are not being captured by ESS.
METHODS: Adults referred to a tertiary sleep clinic undergoing sleep studies completed ESS and LOS questionnaires (20 items with various patient-reported descriptors). LOS was examined in patients who had or did not have OSA without sleepiness based on ESS < 10. Cluster analysis was performed to assess whether or not groups of individuals differed based on classification with or without OSA and with or without ESS-based sleepiness.
RESULTS: Approximately half the study population (n = 185 completed) had OSA. ESS score (mean ± SD) was 9.0 ± 5.4. There was no significant difference in ESS between patients with and without OSA (9.0 ± 5.1 vs 9.1 ± 5.7, p = 0.969). In patients with OSA, females, older patients and white patients were significantly less likely to have an ESS ≥ 10 when compared to patients with an ESS < 10. In patients with an ESS < 10, there were no significant differences in descriptors of sleepiness between patients with and without OSA with the most common descriptors selected being "I lack energy," "I wake up sleepy," "I keep waking up," and "I don't sleep enough."
CONCLUSIONS: The ESS failed to discriminate patients with OSA from those without OSA. Despite an ESS < 10, both daytime and sleep complaints using the LOS questionnaire were present in patients with OSA. Asymptomatic OSA may be less common than previously reported.

Introduction

Obstructive sleep apnea (OSA) is amongst the most common respiratory disorders in the developed world, affecting one seventh of the word’s adult population [1]. OSA is associated with a wide range of adverse health sequelae yet this chronic disorder remains underdiagnosed and untreated [2]. Underdiagnosis may in part be due to the highly variable clinical presentation in OSA.

Excessive sleepiness is regarded as one of the cardinal manifestations of OSA, but subjective sleepiness is not universal [3-5]. Sleepiness is reported by 15–50% of people with OSA identified through general population screening [6]. Moreover, the definition and optimal measurement of daytime sleepiness remains inconsistent and an area of ongoing debate. The Epworth Sleepiness Scale (ESS) is a subjective measure of sleepiness that has been widely adopted in clinical practice to detect and gauge severity of excessive daytime sleepiness, yet the ESS has not been shown to be a reliable screening test for OSA [7]. Often times, a variety of words and phrases are used to describe excessive sleepiness, often interchangeably (e.g., fatigue, drowsiness, weariness, lethargy, and lack of energy) [8]. More so, emphasis is often placed on distinguishing differences between sleepiness and fatigue, but complaints of fatigue may be just as common as that of sleepiness in OSA. Chervin et al. examined preferred words used by patients in describing their complaints in almost 200 adults with moderate to severe OSA—fatigue, tiredness, and lack of energy were more frequently reported than sleepiness [9]. The proportion of patients who preferred the term sleepiness to describe their primary problem was only 22%, suggesting that patients with OSA and their providers may use a diverse set of words to describe their problem.

There is a need to understand better the ways in which sleepiness is described by patients with OSA. In this study, we explored various descriptors of sleepiness using the “Language of Sleepiness” questionnaire in patients referred to a sleep clinic who completed a sleep study. Screening for depression was included as a way to better characterize the patients. The main aims of our study were to (a) compare descriptors of sleepiness in patients diagnosed with OSA who report no daytime sleepiness as defined by the Epworth Sleepiness Scale < 10/24, and (b) to use cluster analysis to identify groups of individuals based on their responses and assess whether these groups differed by OSA status (AHI ≥ 5/h). We hypothesized that asymptomatic OSA is uncommon and that there are descriptors of sleepiness in OSA not being captured by the ESS that may ultimately facilitate diagnosis.

Methods

Participants

Adults aged 18–89 years being evaluated for the first time in the Sleep Clinic at the University of California San Diego between March 2020 and March 2021 were recruited. Patients previously seen for sleep consultation were excluded. Vulnerable patient groups including prisoners and those with cognitive impairment were excluded. The study was approved by the University of California San Diego Institutional Review Board and registered with ClinicalTrials.gov (NCT04323254). Participants electronically signed informed consent prior to initiating the study protocol.

Data collection

All patients completed consultation with a sleep specialist.

Questionnaires

All participants were given the clinical intake form and the following questionnaires using a secure, HIPAA-compliant electronic platform:

Epworth Sleepiness Scale (ESS). The ESS is a self-administered questionnaire assessing an individual’s subjective propensity for daytime sleepiness. Subjects were asked how likely they are to doze off or fall asleep on a scale of 0–3, in 8 specific situations, with total scores ranging from 0 to 24. An ESS score of 10 or greater is considered indicative of subjective excessive daytime sleepiness [10].

“Language of Sleepiness” (LOS) questionnaire. The LOS is a 20-item questionnaire with various descriptors of sleepiness (Table 2). Patients were asked to rank the top 5 descriptors and rank the severity of each descriptor from 0 to 10 with 10 being the more severe. One descriptor, “I keep waking up” appears twice to assess consistency. The questionnaire was developed by our team based on clinical experience and refined based on expert input over the last 2 decades.

Table 2

OSA (AHI ≥ 5/h) patients without (ESS < 10/24) and with (ESS ≥ 10/24) excessive sleepiness

	ESS < 10, n = 48	ESS ≥ 10, n = 42	p value
Age (years)	57.3 ± 13.27	47.9 ± 14.0	0.002
Male sex (%)	26 (54%)	32 (76%)	0.029
White race (%)	36 (77%)	16 (42%)	0.024
Current smoker (%)	1 (2%)	3 (7%)	0.245
Sleep aid use (%)	9 (19%)	9 (21%)	0.789
History of cardiovascular disease (%)	7 (15%)	3 (7%)	0.262
History of psychiatric disease (%)	11 (23%)	13 (31%)	0.390
Apnea–hypopnea index (AHI)	20.6 ± 16.1	20.5 ± 20.4	0.984
Oxyhemoglobin saturation nadir	79.6 ± 9.8	80.2 ± 7.6	0.753
FOSQ-10	15.3 ± 3.1	14.0 ± 2.9	0.045
Beck Depression Inventory-II	10.5 ± 8.0	14.31 ± 9.7	0.040
“Language of Sleepiness” questionnaire
I can’t think clearly	4.3 ± 2.9	3.9 ± 2.4	0.421
I need to sleep in	3.9 ± 2.7	5.1 ± 3.2	0.061
I don’t dream	3.3 ± 2.8	3.5 ± 2.8	0.701
I get overtired	5.0 ± 2.9	5.8 ± 2.7	0.178
I lack energy	5.8 ± 2.8	6.9 ± 2.5	0.046
I need to nap a lot	3.4 ± 2.6	5.1 ± 3.2	0.006
I am exhausted	5.0 ± 3.0	6.5 ± 2.7	0.018
I can’t sleep enough	5.0 ± 3.2	5.7 ± 2.9	0.280
I don’t sleep enough	5.5 ± 3.1	5.7 ± 3.3	0.724
I am always tired	5.7 ± 3.0	6.7 ± 2.8	0.116
I keep waking up (1)	6.4 ± 3.1	6.4 ± 3.0	0.989
I am tired all of the time	5.0 ± 2.9	6.6 ± 2.9	0.015
I can’t stay awake	2.5 ± 2.0	4.1 ± 2.6	0.001
I need to drink coffee	3.1 ± 2.8	4.7 ± 3.3	0.012
I keep waking up (2)	6.3 ± 3.2	6.5 ± 3.0	0.725
I am fatigued	5.4 ± 2.9	6.3 ± 2.7	0.136
I wake up sleepy	5.5 ± 3.0	6.1 ± 3.1	0.396
It takes me a long time to wake up	3.3 ± 2.5	4.2 ± 3.1	0.114
I am often drowsy	3.4 ± 2.2	5.3 ± 2.9	0.001
I can’t concentrate	4.6 ± 3.2	4.7 ± 3.11	0.897

Data are presented as mean ± standard deviation unless otherwise indicated. Bolded values indicate p < 0.05

Functional Outcomes of Sleep Questionnaire (FOSQ-10). The FOSQ-10 is a 10-item questionnaire measuring the impact of daytime sleepiness on activities of daily living. The mean of the total subscales is multiplied by 5 for the final score, with total scores ranging from 5 to 20. A score of 17.8 is considered the cut-off for normal and abnormal functioning [11].

Beck Depression Inventory-II (BDI-II). The BDI-II is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression.

The answers to the questionnaires were recorded to a secure electronic database, REDCap, along with the results of the overnight sleep study, when available, and medical history from the participant’s medical records. The clinical intake form and medical records included demographics, past medical history, medications, and smoking history. REDCap is a password-protected secure Web application and a HIPAA-compliant environment. Participants had a coded study identifier associated with their research documents and questionnaires.

Sleep studies

Sleep studies were performed at the University of California San Diego Sleep Center. The type of sleep study was determined by the evaluating physician at the time of the clinic visit, but was also influenced by insurance mandates. This study was completed during the coronavirus disease 2019 (COVID-19) pandemic. Due to safety concerns, the sleep laboratory was closed for a period of time and most sleep studies were completed as unattended home sleep studies. Attended, overnight polysomnography (PSG) was performed using the Alice 6 LDx Diagnostic sleep system including electroencephalography (F1-M1, C4-M1, O2-M1), bilateral electrooculography, continuous airflow with thermistor and nasal pressure transducer, thoracic, and abdominal respiratory inductance plethysmography, body position, submental and bilateral anterior tibial electromyography, and finger pulse oximetry. Unattended home sleep studies were performed using the Resmed ApneaLink Air™ system including continuous airflow, thoracic respiratory effort, body position, and finger pulse oximetry.

The UC San Diego Sleep Center is accredited by the American Academy of Sleep Medicine and all procedures followed AASM Version 2.6 Scoring Manual recommendations. Hypopneas were scored if the peak airflow signal excursions dropped by ≥ 30% of pre-event baseline for at least 10 s, and there was a > 4% desaturation from pre-event baseline (Acceptable AASM 1B criteria).

Statistical analysis

Data are presented as mean ± SD for continuous variables and n (%) for categorical variable. For comparison of demographic characteristics and sleep study measures between those with and without OSA, t-test was used for continuous variables and Pearson chi-square test for categorical variables.

For the initial analysis, we identified patients with OSA based on an AHI ≥ 5/h and determined which descriptors were most commonly used in association with OSA. In addition, we assessed to what extent the sleep disorder impacts the patient’s perception of his/her quality of life. These analyses included simple correlations for the linear scales and independent samples t-tests to compare different groups based on OSA severity and ESS scores.

We utilized agglomerative hierarchical clustering methods with an average linkage to identify groupings of patients who had similar responses to LOS questions [12]. Hierarchical cluster approaches assign all observations to their own cluster and sequentially merge clusters most similar until there is only one cluster. The optimal number of clusters is determined by visually inspecting a dendrogram (described in greater detail in the “Results” section). Further details about this method can be found elsewhere [12]. We included all LOS variables in the cluster analysis, excluding the second “I keep waking up” variable. After determining the optimal number of clusters and categorizing patients, we described clusters based on the distribution of values for LOS questions, and determined whether they distinguished subjects based on OSA status.

Descriptors of sleepiness were examined in patients with OSA of varying severity but an ESS < 10/24 and compared to patients without OSA. Statistical significance was defined as alpha = 0.05 (two-tailed) for all analyses. All statistical analyses were completed in SPSS (IBM Corp. Released 2021. IBM SPSS Statistics for Windows, Version 28.0, Armonk, NY: IBM Corp). Cluster analysis was completed using Stata SE version 15 (StataCorp, College Station, TX). Based on the exploratory nature of the analyses, no corrections were made for multiple comparisons.

Results

Of 249 participants, complete data were available in 185 participants. Compared to participants with incomplete data, participants with complete data were less likely to smoke, less likely to have a history of cardiovascular disease and had a lower apnea–hypopnea index (see supplement). All analyses reported focused on those with complete data.

Baseline characteristics of participants with complete data are shown in Table 1. The study sample was middle-aged, largely evenly divided between males and females and predominantly white. Approximately half the study population had OSA as defined by a total apnea–hypopnea index ≥ 5/h with a mean ± SD AHI of 20.5 ± 18.4/h. Patients with OSA were more likely to have a history of cardiovascular disease but had significantly lower BDI-II scores and were less likely to have a history of psychiatric disease or use sleep aids when compared to patients without OSA.

Table 1

Baseline characteristics

	Total, n = 185	AHI < 5/h, n = 95	AHI ≥ 5/h, n = 90	p value
Age (years)	46.6 ± 14.5	40.7 ± 12.0	52.9 ± 14.3	< 0.001
Male sex (%)	103 (56%)	45 (47%)	58 (64%)	0.019
White race (%)	112 (64%)	60 (66%)	52 (61%)	0.512
Current smoker (%)	9 (5%)	5 (5%)	4 (4%)	0.796
Sleep aid use (%)	51 (28%)	33 (35%)	18 (20%)	0.028
History of cardiovascular disease (%)	11 (6%)	1 (1%)	10 (11%)	0.004
History of psychiatric disease (%)	70 (38%)	46 (48%)	24 (27%)	0.002
Apnea–hypopnea index (AHI)	10.9 ± 15.8	1.7 ± 1.3	20.5 ± 18.4	< 0.001
Oxyhemoglobin saturation nadir	84.5 ± 8.1	88.9 ± 3.8	79.9 ± 8.8	< 0.001
ESS	9.0 ± 5.4	9.1 ± 5.7	9.0 ± 5.1	0.969
FOSQ-10	14.3 ± 3.3	14.0 ± 3.6	14.7 ± 3.1	0.117
Beck Depression Inventory-II	13.9 ± 9.7	15.5 ± 10.1	12.2 ± 9.0	0.021

Data are presented as mean ± standard deviation unless otherwise indicated. Bolded values indicate p < 0.05

Epworth Sleepiness Scale

In the study sample, ESS score (mean ± SD) was 9.0 ± 5.4/24. There was no significant difference in the ESS between patients with and without OSA defined by an apnea–hypopnea index ≥ 5/h (9.0 ± 5.1 vs 9.1 ± 5.7, p = 0.969). In patients with OSA, females, older patients, and white patients were significantly less likely to have an ESS ≥ 10/24 when compared to patients with an ESS < 10/24 (see Table 2).

“Language of Sleepiness” descriptors

Of the 20 “Language of Sleepiness” descriptors, significant differences were seen for “I lack energy,” “I can’t sleep enough,” “I am always tired,” “I am tired all of the time,” “I am fatigued,” and “I am often drowsy” between patients with and without OSA, with lower (less severe) scores reported in patients with OSA (Table 3).

Table 3

Comparison of “Language of Sleepiness” descriptors between patients without (AHI < 5/h) and with OSA (AHI ≥ 5/h)

	Total, n = 185	AHI < 5, n = 95	AHI ≥ 5, n = 90	p value
I can’t think clearly	4.4 ± 2.9	4.7 ± 3.0	4.1 ± 2.7	0.152
I need to sleep in	4.8 ± 3.1	5.2 ± 3.1	4.4 ± 3.0	0.080
I don’t dream	3.1 ± 2.7	2.8 ± 2.6	3.4 ± 2.8	0.168
I get overtired	5.6 ± 2.9	5.9 ± 3.0	5.4 ± 2.8	0.203
I lack energy	6.7 ± 2.7	7.1 ± 2.6	6.3 ± 2.7	0.042
I need to nap a lot	4.5 ± 3.1	4.8 ± 3.3	4.2 ± 3.0	0.202
I am exhausted	6.1 ± 3.0	6.5 ± 3.1	5.7 ± 2.9	0.092
I can’t sleep enough	5.8 ± 3.1	6.3 ± 3.1	5.3 ± 3.1	0.024
I don’t sleep enough	5.8 ± 3.2	6.1 ± 3.2	5.6 ± 3.1	0.292
I am always tired	6.7 ± 2.9	7.1 ± 2.9	6.2 ± 2.9	0.031
I keep waking up (1)	6.3 ± 3.2	6.3 ± 3.4	6.4 ± 3.0	0.703
I am tired all of the time	6.3 ± 3.0	6.8 ± 3.0	5.7 ± 3.0	0.018
I can’t stay awake	3.5 ± 2.6	3.7 ± 2.7	3.2 ± 2.4	0.193
I need to drink coffee	4.2 ± 3.3	4.5 ± 3.3	3.9 ± 3.2	0.212
I keep waking up (2)	6.3 ± 3.2	6.1 ± 3.4	6.4 ± 3.1	0.614
I am fatigued	6.4 ± 2.9	6.8 ± 2.8	5.9 ± 2.8	0.023
I wake up sleepy	6.1 ± 3.1	6.4 ± 3.1	5.8 ± 3.0	0.167
It takes me a long time to wake up	4.1 ± 3.0	4.5 ± 3.1	3.7 ± 2.8	0.060
I am often drowsy	4.7 ± 2.9	5.2 ± 3.0	4.3 ± 2.7	0.033
I can’t concentrate	4.9 ± 3.1	5.1 ± 3.1	4.6 ± 3.1	0.286

Data are presented as mean ± standard deviation. Bolded values indicate p < 0.05

In patients with an ESS < 10, there were no significant differences in descriptors of sleepiness between patients with and without OSA (Table 4) with the most common descriptors selected being “I lack energy,” “I wake up sleepy,” “I keep waking up,” and “I don’t sleep enough.” However, various complaints were common in those with ESS < 10 who are sometimes labeled “asymptomatic.”

Table 4

Comparison of “Language of Sleepiness” descriptors for those with an ESS < 10 without and with OSA defined by an apnea–hypopnea index ≥ 5/h

Epworth Sleepiness Scale < 10
	Total, n = 102	AHI < 5, n = 54	AHI ≥ 5, n = 48	p value
Age (years)	48.4 ± 14.9	40.4 ± 11.4	57.3 ± 13.3	0.000
Male sex (%)	48 (47%)	22 (41%)	26 (54%)	0.175
White race (%)	68 (69%)	32 (62%)	36 (77%)	0.386
History of cardiovascular disease (%)	7 (7%)	0 (0%)	7 (15%)	0.004
History of psychiatric disease (%)	39 (38%)	28 (52%)	11 (23%)	0.003
Apnea–hypopnea index (AHI)	10.6 ± 14.5	1.7 ± 1.4	20.6 ± 16.1	0.000
Oxyhemoglobin saturation nadir	84.5 ± 8.5	95.1 ± 1.8	79.6 ± 9.8	0.000
FOSQ-10	15.2 ± 3.4	15.0 ± 3.6	15.3 ± 3.1	0.616
Beck Depression Inventory-II	12.3 ± 9.4	14 ± 10.2	10.4 ± 8.0	0.528
“Language of Sleepiness” questionnaire
I can’t think clearly	4.4 ± 3.1	4.5 ± 3.3	4.3 ± 2.9	0.718
I need to sleep in	4.2 ± 2.8	4.5 ± 2.9	3.9 ± 2.7	0.253
I don’t dream	2,8 ± 2.6	2.5 ± 2.3	3.3 ± 2.8	0.123
I get overtired	5.2 ± 2.9	5.3 ± 3.0	5.0 ± 2.9	0.543
I lack energy	6.2 ± 2.9	6.5 ± 2.9	5.8 ± 2.8	0,240
I need to nap a lot	3.5 ± 2.8	3.7 ± 2.9	3.4 ± 2.6	0.624
I am exhausted	5.4 ± 3.0	5.7 ± 3.0	5.0 ± 3.0	0.244
I can’t sleep enough	5.4 ± 3.2	5.7 ± 3.1	5.0 ± 3.2	0.238
I don’t sleep enough	5.6 ± 3.2	5.7 ± 3.3	5.5 ± 3.1	0.700
I am always tired	6.0 ± 3.0	6.3 ± 2.9	5.7 ± 3.0	0.367
I keep waking up (1)	6.1 ± 3.4	5.9 ± 3.6	6.4 ± 3.1	0.384
I am tired all of the time	5.5 ± 2.9	5.9 ± 3.0	5.0 ± 2.9	0.164
I can’t stay awake	2.4 ± 2.1	2.4 ± 2.2	3.5 ± 2.0	0.801
I need to drink coffee	3.4 ± 2.9	2.7 ± 3.0	3.1 ± 2.8	0.330
I keep waking up (2)	6.1 ± 3.4	5.9 ± 3.6	6.3 ± 3.2	0.591
I am fatigued	5.9 ± 2.9	6.2 ± 2.8	5.4 ± 2.9	0.170
I wake up sleepy	5.5 ± 3.0	5.6 ± 3.1	5.5 ± 3.0	0.926
It takes me a long time to wake up	3.6 ± 2.8	3.9 ± 3.1	2.5 ± 1.2	0.216
I am often drowsy	3.7 ± 2.5	4.0 ± 2.7	2.2 ± 1.2	0.221
I can’t concentrate	4.7 ± 3.2	4.8 ± 3.3	3.2 ± 0.3	0.766

Data are presented as mean ± standard deviation unless otherwise indicated. Bolded values indicate p < 0.05

Cluster analysis

A dendrogram from the cluster analysis is shown in Fig. 1. Dendrograms are graphical depictions that map the hierarchical clustering of observations. Each cluster is represented at the bottom of the figure. The two closest clusters are merged until one cluster remains at the top of the figure. Vertical lines represent distance between clusters, and horizontal lines represent clusters that are merged. For example, cluster G1 and G2 merge, which is then subsequently merged with G3. The optimal number of clusters can be determined by identifying the number of vertical lines with the largest distance between cluster merges (e.g., horizontal lines). Based on the dendrogram, we decided that two clusters are appropriate. Please note that due to the large number of observations, we limited the dendrogram to the top 15 clusters, and thus the long lines at the bottom of the graph can be ignored.

Fig. 1

Dendrogram for Language of Sleepiness questions

Figure 2 depicts box plots of the severity ratings for each LOS item in cluster 1 (n = 127) and cluster 2 (n = 58). Cluster 1 is characterized by moderate to high severity for each LOS item except for “I don’t dream,” and “I can’t stay awake” (both of which for the most part had lower severity levels). Cluster 2 is characterized by low severity on most LOS items. OSA status did not differ across clustered groups (cluster 1 = 44.9% has AHI ≥ 5/h, cluster 2 = 56.9%, p = 0.129).

Fig. 2

Distribution of severity levels for “Language of Sleepiness” items in cluster 1 and cluster 2

Discussion

In patients referred to our sleep clinic, excessive sleepiness using an Epworth Sleepiness Score ≥ 10 failed to discriminate patients with OSA from those without OSA. Based on the original observation of a mean ESS score of 12 in patients with moderate to severe OSA as compared to 6 in normal healthy controls, an ESS score of ≥ 10 has been widely adopted in clinical practice to define sleepiness [10]. However, few high quality studies have explored its test properties and when evaluating the performance of the ESS against polysomnography in identifying patients with OSA, the ESS had a large number of false negative results [7]. When considering an AHI of ≥ 5/h, the ESS has revealed a range of sensitivity of 0.27–0.72, specificity of 0.5–0.76, and accuracy of 51–59% [7]. No consistent association between severity of OSA and degree of excessive sleepiness has been shown [13-17]. In a large community-based cohort, the Sleep Heart Health Study, only 46% of 6440 participants with moderate to severe OSA based on an AHI of ≥ 15/h reported sleepiness defined using an ESS ≥ 10 or a report of at least frequently feeling unrested or sleepy [5]. Additionally, there are limited data on the ESS test–retest reliability. Yet, great weight is often placed on sleepiness and the ESS when diagnosing OSA and sleepiness is included as one diagnostic criteria for OSA by the International Classification of Sleep Disorders.

In Chervin’s observational study looking at preferred terms used to describe symptoms in OSA, fatigue, tiredness, and lack of energy were reported more frequently than sleepiness (57%, 61%, 62% vs 47%) and when asked to select the one most significant symptom, lack of energy was selected more than any other symptoms in patients with OSA [9]. Forty-four percent of patients considered lack of energy as their most limiting symptom compared to 16% for sleepiness. The authors also showed there was generally no association between each symptom and objective, “gold standard” polysomnographic measures of OSA severity or daytime sleepiness, arguing that the daytime subjective consequences of OSA are complicated. In a community sample of 837 adult men who completed a sleep study, sleepiness defined using ≥ 2 of 3 problems (feeling sleepy sitting quietly; feeling tired/fatigued/sleepy; trouble staying awake) but not the ESS was associated with OSA [18].

Our study confirms these findings and raises questions about whether sleepiness is a distinguishing characteristic of OSA. We found a range of descriptors of sleepiness used by patients with OSA. Additionally, there were relatively few differences in LOS item severity between those with and without an AHI of ≥ 5/h. Furthermore, clustering individuals based on profiles of sleepiness severity also did not fully distinguish individuals by OSA status. Paradoxically, patients with an AHI of ≤ 5/h had greater severity on some LOS items. The lack of significant differences in descriptors of sleepiness using the “Language of Sleepiness” between patients with and without OSA in our study is not surprising as sleepiness is multidimensional. Terri Young elegantly discusses the complexity of daytime sleepiness, with contributions from distinct drives of sleep and alertness, varying etiologies, state and trait considerations, and a wide spectrum of consequences, resulting in a need for a variety of definitions in order to address clinical questions [8]. Although relating to different underlying concepts, excessive sleepiness and fatigue can show overlapping features and patients can present with both complaints simultaneously [19]. Sleepiness and fatigue can also be independent manifestations of sleep disorders [20]. Thus, based on our findings, emphasis on sleepiness in OSA may be an impediment to accurate diagnosis.

Additionally, our study showed that females, older and white patients with OSA were significantly less likely to report sleepiness using an ESS ≥ 10. The potential gender differences in the expression of sleepiness is not new, with men reporting sleepy behavior and women reporting feelings of excessive sleepiness [8]. Similar to our study, in the Sleep Heart Health Study, Baldwin et al. found men and women answered questions on sleepiness differently [21]. Women reported feeling sleepy as often as men did, but women were less likely to have an ESS ≥ 10 and more likely to report feeling unrested than men. In men, the ESS was more strongly correlated with reports of feeling unrested or sleepy compared to women [21]. Chervin found the female gender was associated with a markedly increased frequency of all symptoms, although the differences for sleepiness was the smallest between females and males. In a study comparing clinical and polysomnographic features of OSA between 2052 males and 775 females with OSA, females more frequently reported fatigue and insomnia symptoms [22]. Some of these differences may be due to cultural factors. “Sleepiness” may be perceived as a sign of personal weakness while tiredness may be associated with working hard and thus be the less stigmatized term, but there may be also variation in sensitivity to the sensations of sleepiness [23]. Sforza et al. studied the presence of sleepiness in elderly patients with OSA and found the prevalence of EDS was low in healthy elderly patients with OSA highlighting the multiple potential influences on sleepiness [24].

Identifying and characterizing sleepiness may go beyond diagnosis and have prognostic and therapeutic implications in OSA. Using data from the Sleep Heart Health Study, the excessively sleepy symptom subtype was associated with more than threefold increased risk of prevalent heart failure and increased risk of cardiovascular disease compared with asymptomatic or moderately sleepy symptom subtypes [25]. In a 2012 meta-analysis of the effect of CPAP treatment on BP, reductions in DBP with PAP were predicted by ESS scores [26]. Much of the criticism for the negative randomized trials on CPAP in cardiovascular outcomes has been the exclusion of this sleepy subtype who may be at higher risk for cardiovascular disease. In aggregate, the data have found no cardiovascular benefit of CPAP in patients with OSA but subjects were not excessively sleepy [27-29].

Our study had limitations due to COVID-19 which was declared a pandemic by the WHO in March 2020 when patient enrollment began. The impact of COVID-19 on sleep is yet to be determined [30]. We had planned to examine the relationship between descriptors of sleepiness and objective polysomnographic measures of OSA pathology including various measures of OSA severity, but for safety reasons, most sleep studies were completed as unattended home sleep studies. Additionally, this study population ended up having mild OSA with only 29 patients with moderate and 15 with severe OSA, limiting analyses by OSA severity. Our study did not explore descriptors of sleepiness in sleep conditions other than OSA. The cohort was not selected for depressive symptoms and specific data on depressive course or sleep disturbances; thus, we were not able to closely examine the relationships of sleepiness and OSA with depression.

Our findings question the emphasis that is often placed on sleepiness and the ESS score in patients with OSA. Patients with OSA may use various daytime complaints and descriptors of sleepiness, and the clinical decision of whether or not to pursue diagnostic testing for OSA should not rely on a single ESS metric. Subjective measures of sleepiness likely only capture a limited aspect of a heterogeneous and multidimensional entity. Further studies exploring potential gender, age, and cultural influences on descriptors of sleepiness in various sleep disorders are required.

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 13 KB)